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A guanine-nucleotide-binding protein (G-protein) was purified from cholate extracts of bovine brain
membranes by sequential DEAE-Sephacel, Ultrogel AcA-34, heptylamine-Sepharose and Sephadex G- 150
chromatography. Guanosine 5'-[y-[35S]thio]triphosphate (GTP [35S])-binding activity copurified with a
25000 Da peptide and a 35000-36000 Da protein doublet. Neither pertussis toxin nor cholera toxin
catalysed the ADP-ribosylation of a protein associated with the GTP[35S]-binding activity. Photoaffinity
labelling of the purified protein with 8-azido[y-32P]GTP indicated that the GTP-binding site resides on the
25000 Da protein. The 35000-36000 Da protein doublet was electrophoretically indistinguishable from
the fl-subunits of other GTP-binding proteins, and the 36000 Da protein was recognized by antiserum to
oligomeric Gt. The purified protein specifically bound 17.2 nmol of GTP[35S]/mg of protein. The Kd of the
binding site for radioligand was approx. 15 nm. The brain GTP-binding protein co-migrated during
SDS/polyacrylamide-gel electrophoresis with a GTP-binding protein, named Gp, purified from human
placenta [Evans, Brown, Fraser & Northup (1986) J. Biol. Chem. 261, 7052-7059], and cross-reacted with
antiserum raised against the placental protein, but not with antiserum raised to brain Go.
SDS/polyacrylamide-gel electrophoresis of the brain and placental GTP-binding proteins in the presence
of Staphylococcus aureus V8 protease yielded identical peptide maps.
INTRODUCTION
A family of structurally and functionally homologous,
membrane-associated, guanine-nucleotide-binding regu-
latory proteins (G-proteins) subserves an obligatory
function in a variety of transmembrane signalling
processes (Gilman, 1984). G5, Gi and Gt are the
functionally recognized members of this family in that
the enzymes subject to modulation have been identified,
i.e. hormone-sensitive adenylate cyclase and retinal cyclic
GMP phosphodiesterase. G-proteins also have been
implicated as transducing elements in the hormone-
receptor-mediated regulation of phospholipid metab-
olism (Cockcroft & Gomperts, 1985; Litosch et al., 1985)
and ion channels (Pfaffinger et al., 1985; Breitwieser &
Szabo, 1985; Andrade et al., 1986; Hescheler et al., 1987;
Sasaki & Sato, 1987). The identity of the G-proteins
involved in these signalling systems has not been
established.
The probability that many of the multifarious
processes of communication in the central nervous
system involve signalling mechanisms unrelated to the
regulation of adenylate cyclase has prompted interest in
the identification and purification of novel G-proteins
from brain. For example, several laboratories have
reported the purification of a G-protein called 'G.' that
apparently possesses the characteristic afly oligomeric
subunit structure of the G-proteins of known function,
and that, like Gi and Gt, is a substrate for pertussis-
toxin-catalysed ADP-ribosylation (Sternweis & Robi-
shaw, 1984;' Neer et al., 1984; Milligan & Klee, 1985;
Katada et al., 1986). We now report the identification
and purification of a 'new' GTP-binding activity from
bovine brain membranes. The GTP-binding protein has
a molecular mass of 25000 Da, co-purifies with a
characteristic 35000-36000 Da doublet, which most
likely represents a fl-subunit, and is electrophor-
etically, structurally and immunologically identical
with a GTP-binding protein called 'Gp ' recently purified
from placenta.§
Abbreviations used: G-protein, any GTP-binding protein that resembles a family of homologous proteins, composed to date of G., Gi, Go and
Gt; G. and Gi, the identified regulatory components of adenylate cyclase that mediate stimulation and inhibition respectively; Gt, transducin from
retinal rod outer segments; G., a GTP-binding protein originally purified from membranes of bovine brain; Gp, a GTP-binding protein originally
purified from placenta membranes; ARF, the protein factor necessary for cholera-toxin-catalysed ADP-ribosylation of G,; GTP[SJ, guanosine
5'-[y-thio]triphosphate; p[NHJppA, 5'-adenylyl imidodiphosphate; PAGE, polyacrylamide gel electrophoresis.
To whom all correspondence should be addressed.
§ A protein called 'Gp' has been purified previously from human placenta and platelet (Evans et al., 1986). To date there is no evidence that this
protein is equivalent to the putative G-protein 'Gp' implicated in receptor-mediated regulation of phosphoinositide hydrolysis. In the present work
a protein was purified from bovine brain that is electrophoretically, immunologically and structurally indistinguishable from the protein previously
purified from placenta. Owing to the recently widespread acceptance of the term 'Gp' in the phosphoinositide-signalling field, it iS probably less
confusing to refer to the protein studied here as 'Ga 25000' until a physiological role for the brain protein can be established.
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EXPERIMENTAL
Membrane preparation
Fresh bovine brains were placed on ice and transported
to the laboratory, where all subsequent procedures were
performed at 4 'C. The cerebral cortices were dissected
free from cerebellum and brain stem, and placed in
10% (w/v) sucrose/20 mM-Tris (pH 7.5)/O.1 mm-
phenylmethanesulphonyl fluoride/0.1 mM-benzamidine.
Meninges, large blood vessels and blood clots were
removed, and the tissue was minced with scissors and
homogenized in 4 vol. of buffer with a Waring blender
and a Polytron. The resulting suspension was filtered
through gauze, and membranes were collected by
centrifugation for 20 min at 38000g. The membrane
pellets were washed twice by resuspension in 4 vol. of
buffer with a Polytron, followed by centrifugation for
20 min at 38000g. The final pellet was resuspended
to a protein concentration of approx. 10 mg/ml and
stored at -80 'C.
G-protein purification
Membranes (7-10 g of protein) were thawed rapidly
in a 35 'C water bath and collected by centrifugation at
38000 g for 30 min at 4 'C. The pelleted membranes
were washed once with TED buffer (20 mM-Tris, pH 8.0,
1 mM-EDTA, 1 mM-dithiothreitol and 0.1 mM-benz-
amidine). The washed membranes were resuspended to
2 litres with TED buffer containing a final concen-
tration of 1 % sodium cholate and incubated with constant
stirring at 4 'C for 60 min. The bulk of the extracted
membranes was removed by centrifugation at 38000 g
for 20 min. The supernatant was collected, and the
remaining membranes were removed by centrifugation
at 200000 g for 60 min. The supernatant (1660 ml) was
collected as the soluble extract.
The extracted material was applied (flow rate
0.75 ml/min) to a 430 ml (2.5 cm x 88 cm) column of
DEAE-Sephacel (Pharmacia) equilibrated with 2 litres of
TED/i % sodium cholate. The column was washed with
1 bed volume of equilibration buffer, and the proteins
were eluted with a 900 ml linear gradient of 0-175 mM-
NaCl in TED/i% sodium cholate; .10 ml fractions
were collected. The column then was washed sequentially
with 200 ml of 175 mM-NaCl, 400 ml of 250 mM-NaCl
and 500 ml of 500 mM-NaCl, all in TED/i % sodium
cholate.
The trailing shoulder of the large peak of GTP[35S]-
binding activity (fractions 85-125; 380 ml) that was
eluted from the DEAE-Sephacel column (Fig. 1) was
pooled and concentrated to approx. 36 ml by pressure
filtration through an Amicon PM-10 membrane. The
material was applied to a 422 ml column (2.5 cm x 86 cm)
of Ultrogel AcA-34 (LKB) at a flow rate of 0.3 ml/min
and eluted with TED/ 1 % sodium cholate/100 mM-NaCl;
3.2 ml fractions were collected (Fig. 2).
The second peak of GTP[35S]-binding activity eluted
from Ultrogel AcA-34 (fractions 110-128; 59 ml) was
pooled and diluted with 177 ml of TED/100 mM-NaCl.
This diluted pool was applied (flow rate 0.3 ml/min) to
an 81 ml (1.5 cm x 46 cm) column of heptylamine-
Sepharose previously equilibrated with TED/0.25%
sodium cholate/I00 mM-NaCl. The column was washed
with 40 ml of TED/0.25% sodium cholate/100 mM-
NaCl, followed by 50 ml of TED/0.25% sodium
cholate/300 mM-NaCl. The GTP[35S]-binding activity
was then eluted with a 320 ml linear gradient of
TED/0.25% sodium cholate/200 mM-NaCl to TED/
1.3% sodium cholate/50 mM-NaCl; 2.8 ml fractions
were collected in polypropylene tubes. The column was
washed with an additional 80 ml of TED/1.3%
sodium cholate/50 mM-NaCl and regenerated with
TED/I% sodium cholate/500 mM-NaCl/7 M urea.
The single peak of GTP[35S]-binding activity (fractions
80-105; 70 ml) from the heptylamine-Sepharose column
(Fig. 3) was pooled and concentrated by pressure
filtration through an Amicon PM-10 membrane to a
volume of 5 ml. This material was applied to a 127 ml
(1.5 cm x 72 cm) column of Sephadex G-150 (superfine
grade) and eluted with TED/i % sodium cholate/100
mM-NaCl (flow rate 0.074 ml/min); 0.9 ml fractions
were collected in polypropylene conical microfuge tubes.
Two independent pools were taken; the first (fractions
70-86; 15 ml) contained one major contaminant, of
47000 Da, in addition to 25000 Da and 35000-36000
Da proteins, and a second pool (fractions 87-94; 6.8 ml)
consisted' of the 25000 Da and 35000 Da proteins. These
two pools were concentrated by pressure filtration
through an Amicon PM-10 membrane- to final-volumes
of 0.75 and 1.12 ml respectively. The proteins were
stored frozen at -80 'C.
Assays
Binding of GTP[35S] to G-proteins was determined by
methods previously described (Northup et al., 1982),
with minor modifications. In the standard assay, 10 ,1
of sample was diluted with 90 ,ul of a solution containing
20 mM-Hepes, pH 8.0, 1 mM-EDTA, 1 mM-dithiothreitol
and 0.1% Lubrol. The binding reaction was initiated
by the additon of 100l1 of a solution containing
50 mM-Hepes, pH 8.0, 1 mM-EDTA, 100 mM-MgCl2,
200 mM-NaCl, 4 ,eM-GTP[S] and GTP[35S] (105 c.p.m.).
The assays were incubated at 30 'C for 60 min, and the
reaction was terminated by diluting the samples with
4 ml of ice-cold wash buffer [20 mM-Tris (pH 8.0)/
25mM-MgCl2/lOOmM-NaCl] followed by rapid filtra-
tion through BA85 nitrocellulose filters (Schleicher and
Schuell). The filters were washed with 4 x 4 ml of
cold wash buffer, dried, placed in 4 ml of scintillation
fluid, and the retained radioactivity was measured
in a scintillation counter. Scatchard analysis of the
binding of GTP[35S] to the purified protein (second pool
from the Sephadex G-150 column) was accomplished
by varying the concentration of non-radioactive GTP[S]
from 1 to 100 nm in the presence of a constant amount
of GTP[35S]. Specific activities were calculated for each
ligand concentration, and these activities were used to
calculate the mol of bound ligand at a respective
free ligand concentration. Non-specific binding (in the
presence of 100 ,M-GTP[S]) was less than 5°% of the
total radioactivity retained by the filter.
Pertussis-toxin-catalysed ADP-ribosylation of the
41000 and 39000 Da a-subunits of Gi and G. was
carried out essentially as described by Bokoch et al.
(1984). The ribosylation reaction was initiated by
addition of 5 #1 of a column fraction to 95 1ld of a
reaction mixture such that the final concentrations of
reagents were: 1O mM-thymidine, 1 mM-ATP, 0.2 mM-
GTP, 2.5 mM-MgCl2, 1 mM-EDTA, 10 mM-dithio-
threitol, 100 mM-Tris, pH 8.0, 1 mg of phospha-
tidylcholine (egg yolk)/ml, 10 pM-NAD+, 107 c.p.m. of
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[32P]NAD+ and 13.5 ,ug ofpertussis toxin/ml. Incubation
was for 90 min at 30 °C, and the reaction was terminated
by the addition of 500 ,u of 3% SDS containing 10 /cg
of bovine serum albumin/ml. Protein was precipitated
by addition of 500 ,u1 of cold 30% (v/v) trichloroacetic
acid. The precipitated samples were rapidly filtered
through BA85 nitrocellulose filters and washed with
5 x 4 ml of cold 6% trichloroacetic acid, dried, placed
in 4 ml of scintillation fluid, and radioactivity was
quantified in a scintillation counter.
Photoaffi'nity labelling of the purified guanine-
nucleotide-binding protein with 8-azido[y-32P]GTP was
performed as described elsewhere (Evans et al., 1986).
Briefly, 5 #1 ofpurified protein (- 2.75 ,ug) was incubated
on ice for 10 min in a final reaction volume of 100 ,1l. The
reaction contained the following reagents (final concns.):
50 mM-Hepes, pH 8.0, 1 mM-EDTA, 100 mM-NaCl,
20 mM-MgCi2, 0.1 % Lubrol, 50 /M-dithiothreitol and
5 #cM-8-azido[y-32P]GTP (sp. radioactivity 12.7 Ci/
mmol). The samples were irradiated at a distance
of 2.5 cm for 5 min with a Mineralite UVG-54 lamp
(254 nm). Additional purified protein (10lg) was added
as a carrier, and the samples were precipitated over-
night at 4 °C with trichloroacetic acid in the presence
of 2% SDS. The samples were prepared for electro-
phoresis as described below and subjected to SDS/PAGE
on a linear gradient gel of 11-14% acrylamide.
Immunoblots
Purified G-proteins (5 ,ug/lane) were loaded on a
linear gradient gel (11-14% acrylamide) and subjected to
SDS/PAGE. Upon completion of electrophoresis, the
gel was removed and soaked for 20 min in a solution
containing 25 mM-Tris, pH 8.3, 192 mM-glycine, 20%
(v/v) methanol and 0.1 % SDS. The proteins were
electrophoretically transferred (30 V for 12-14 h at
4 °C) from the gel to a nitrocellulose sheet. The blot
was washed twice with 20 mM-Tris (pH 7.5)/500 mM-
NaCI, and the remaining protein-binding sites were
blocked by incubating the nitrocellulose sheet for
30 min in 3% bovine serum albumin/20 mM-Tris
(pH 7.5)/500 mM-NaCl. The immunoblots were
incubated overnight at room temperature with a
polyclonal antiserum raised against the a-subunit of
bovine brain Go, the a-subunit of human platelet Gp, or
oligomeric Gt. The primary antibody was removed and
the blot washed twice with 20 mM-Tris (pH 7.5)/500 mm-
NaCl/0.05% Tween 20, and once with 20 mM-Tris
(pH 7.5)/500 mM-NaCl. The nitrocellulose sheet was
then incubated with a 1:1000 dilution of anti-rabbit
IgG-alkaline phosphatase conjugate (Sigma Chemical
Co.) in 20 mM-Tris (pH 7.5)/500 mM-NaCl/1 % albumin
for 1-2 h. The blot was washed three times with
20 mM-Tris (pH 7.5)/500 mM-NaCl/0.05% Tween 20,
and developed with 0.5 mg of 5-bromo4-chloroindol-
3-yl phosphate/ml in 1 M-Tris, pH 8.8.
SDS/PAGE
Electrophoresis of polypeptides through linear gra-
dient gels of 11-14% polyacrylamide was accomplished
with the discontinuous system described by Laemmli
(1970). Purified G from human placenta and the
purified G-protein ?rom bovine brain also were electro-
phoresed through single-concentration gels of 10, 12, 14
and 16% acrylamide. Ferguson plots were constructed
(Neville, 1971; Ferguson, 1964) and used to determine
the apparent molecular mass of the a-subunit. Except for
samples labelled with 8-azido[a-32P]GTP, all samples
were alkylated with N-ethylmaleimide before electro-
phoresis as described by Sternweis & Robishaw (1984).
This alkylation procedure enhanced the clarity and
resolution of polypeptide bands. All gels were run at
6 'C. Proteins were detected with Coomassie Blue or
silver as described previously (Evans et al.,': 1986). Auto-
radiography of photoaffinity-labelled samples was
accomplished by exposing the dried gels to Kodak
XAR-5 film in DuPont Cronex Hi-Plus intensifying
screens at -80 'C. Molecular-mass standards were
obtained from Bio-Rad and LKB. Staphylococcus aureus
V8 protease (Boehringer-Mannheim) digestion of the
purified G-proteins was accomplished by the method
of Lam & Kasper (1980).
Protein assay
Proteins were measured by the method of Lowry et al.
(1951), and the method described by Schaffner &
Weissman (1973), using Amido Black. Bovine serum
albumin was used as the standard for both assays.
Materials
Sodium cholate (Sigma) was re-purified by the method
described by Ross & Schatz (1978). [32P]Pi and
8-azido[y-32P]GTP (12.7 Ci/mmol) were obtained from
ICN Radiochemicals, and GTP[35S] (1022 Ci/mmol)
was from New England Nuclear. GTP[S] and p[NH]ppA
were from Boehringer-Mannheim. Heptylamine-Seph-
arose was prepared from monoaminoheptane by the
method of Shaltiel (1974) with modifications (Northup
et al., 1980). The method of Cassel & Pfeuffer (1978)
was used to prepare [32P]NAD+, and pertussis toxin was
purified from cultures of Bordetella pertussis as described
previously (Hughes et al., 1984).
RESULTS
Soluble extract from bovine brain membranes was
bound to DEAE-Sephacel and eluted with a gradient of
NaCI (Fig. 1). Approx. 40% of the GTP[35S]-binding
activity in the cholate extract was recovered from
DEAE-Sephacel. GTP[35S]-binding activity was eluted as
one major broad, asymmetrical, peak of relatively high
specific activity and two smaller peaks of relatively low
specific activity. The asymmetry of this main peak was
observed in seven independent preparations under
several elution conditions. In one preparation, two
distinct peaks of GTP[35S]-binding activity were resolved
at these concentrations of NaCI.
Since at least the a-subunits of Gi and Go are
substrates for ADP-ribosylation by pertussis toxin, the
elution pattern of proteins labelled in the presence of
[32P]NAD+ and pertussis toxin was determined. A
symmetrical peak (fractions 65-90) of 32P-labelled
substrate was eluted with the first half of the major peak
of GTP[35S]-binding activity (Fig. 1). Pertussis toxin
catalysed the [32P]ADP-ribosylation of 39000 and 41000
Da proteins in these fractions, as determined by
autoradiography of samples subjected to SDS/PAGE
(G. L. Waldo, unpublished work). In contrast, the trail-
ing edge of the major peak of GTP[35S]-binding activity
contained very little pertussis-toxin substrate. A 35000
and 36000 Da protein doublet could be detected across





























Fig. 1. DEAE-Sephacel chromatography of bovine brain cholate extract
Proteins were eluted from the column with a 900 ml linear gradient of 0-175 mM-NaCl; 10 ml fractions were collected. The
NaCl concentration (o o o) of the eluate was determined by measuring the conductivity of each fraction. The elution of protein
from the column, expressed as A280 (------), was monitored with an absorbance detector attached to the column outlet.
GTP[35S]-binding activity (A) and pertussis-toxin substrate (0) were measured by filtration assay. Fractions 85-125 were pooled

































distribution of a protein of 25000 Da corresponded well
to the trailing shoulder (fractions 85-120) of GTP[35S]-
binding activity. These fractions were pooled, concen-
trated, and chromatographed through Ultrogel AcA-34
(Fig. 2a). The GTP[35S]-binding activity was eluted as
two peaks. The first peak apparently contained G. and
Gi, as indicated by pertussis-toxin-catalysed [32P]ADP-
ribosylation. The second peak comprised most of the
GTP-binding protein, and contained very little pertussis-
toxin substrate. As with the shoulder ofGTP[35S]-binding
activity that was eluted from DEAE-Sephacel, the
prominent GTP[35S]-binding activity from AcA-34
co-eluted with a protein of 25000 Da (Fig. 2b). Thus
selective pooling of the broad peak of GTP[35S]-binding
activity that was eluted from DEAE-Sephacel allows the
clear resolution of two peaks of activity. on elution of that
material from AcA-34.
AcA-34 fractions 110-128 were pooled, diluted to a
final cholate concentration of 0.25%, and chromato-
graphed through heptylamine-Sepharose. The GTP[35S]-
binding activity was eluted as a single peak (Fig. 3a).
A small amount of material labelled in the presence of
[32P]NAD+ and pertussis toxin was eluted before that
peak. The major protein bands associated with the
GTP[35S]-binding activity were a 35000-36000 Da
protein doublet, a 25000 Da protein and a 47000 Da
protein (Fig. 3 b).
25 , Ot -~~~~~~~~~~~~21.5
14.4
Fig. 2. Ultrogel AcA-34 chromatography of the 25000 Da-
protein-enriched pool from DEAE-Sephacel
(a) Elution profiles of GTP[35S]-binding activity (A),
pertussis-toxin substrate (0) and-A280 (----) are shown;
3.2 ml fractions were collected. Horizontal bar indicates
fractions pooled for next step. (b) SDS/PAGE of fractions
obtained from Ultrogel AcA-34. Samples of-the indicated
fractions were alkylated with N-ethylmaleimide and
dissolved in sample buffer. Lanes of a linear gradient gel
consisting of 11-14% acrylamide were loaded with 20 ,u1
of prepared sample containing 5,ul of a column fraction.
Proteins were detected with silver stain. Protein standards
are indicated on the right.
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protein stained by silver and Coomassie Blue, respect-
ively, was associated with these proteins.
A summary of the quantification of the GTP[35S]-
binding activity co-purifying with the 25000 Da protein
is presented in Table 1. It should be noted that
GTP[35S]-binding assays were carried out at a single
concentration of radioligand. Thus the data do not
represent true specific activities of the protein(s). Also, it
was not possible to quantify that amount of GTP[35S]_
binding activity in the original cholate extract that
represented the 25000 Da-associated GTP[35S]-
binding activity. Thus the values for recovery presented
in Table 1 are relative to the total GTP[35S]-binding




Fig. 3. Heptylamine-Sepharose chromatography of the. 25000
Da-protein-enriched pool from Ultrogel AcA-34
(a) Elution profiles of GTP[35S]-binding activity ()
pertussis-toxin substrate (0) and A280 (----) are shown;
2.8 ml fractions were collected. (b) SDS/PAGE of
fractions obtained from heptylamine-Sepharose. Samples
were prepared and loaded as described in Fig. 2. Proteins
were detected with silver stain.
The pool (fractions 80-105) of GTP[35S]-binding
activity from heptylamine-Sepharose was concentrated
and applied to a Sephadex G- 150 (superfine) gel-filtration
column (Fig. 4a). Although no pertussis-toxin substrate
could be detected by filtration assay of fractions from this
column, autoradiography of SDS/PAGE gels with long
exposure in intensifying screens revealed very low
amounts of [32P]ADP-ribosylated proteins of approx.
39000 and 41000 Da in fractions 70-80 (G. L. Waldo,
unpublished work). Relatively small amounts of proteins
of 39000 and 41000 Da also were silver-stained on
SDS/PAGE gels of these fractions (Fig. 4b). The major
silver-stained proteins were of 25000, 35000-36000 and
47000 Da. In contrast, on the basis of both silver
staining of SDS/PAGE gels and autoradiography of
samples labelled in the presence of pertussis toxin and
[3'P]NAD+, no G1 or G. could be detected in fractions
87-94. The major protein bands in these fractions were
the 35000-36000 Da doublet and the 25000 Da protein.
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Fig. 4. Sephadex G-150 (superfine) chromatography of the
25000 Da-protein-enriched pool from heptylamine-
Sepharose
(a) Elution profiles of GTP[35S]-binding activity (AL) and
A2810 (----) are shown; 0.9 ml fractions were collected. (b)
SDS/PAGE of fractions obtained from Sephadex G-l150.
Samples were prepared and loaded as described in Fig. 2.
Proteins were detected with silver stain.
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Table 1. Purification of a G-protein containing a 25000 Da GTP-binding subunit
Preparation of membranes, detergent extraction, and the steps of purification are described in detail in the Experimental and
Results sections. Recovery values represent the percentage of total GTP(SJ binding in brain extract that was recovered in the
25 Da protein pool.
GTP(S] binding
Fractions Volume Protein Recovery



















































Fig. 5. Scatchard analysis of GTPI365S] binding to the purifie
protein
Purified protein (see Fig. 7a, lane 3, for Coomassie-
Blue-stained gel of the purified protein pool) from the
Sephadex G-1 50 pool (fractions 87-94) was incubated with
GTP[35,S] (160000 c.p.m./assay) and various concen-
trations of GTP[SJ to generate saturation-binding
isotherms as described in the Experimental section. Values
for KD and Bmax.. derived from Scatchard analysis
generated from these data were 15 nm and 17 pmol/psg of
protein respectively.
activity in the extract, not to the starting amount of
25000 Da-protein-associated binding activity. In
general, fractions were pooled to obtain the highest
purity and not necessarily the best yield. Values in Table
I also do not account for removal of samples for various
assays during the purification.
Saturation-binding isotherms for GTP[35S] were gene-
rated with the purified protein. Transformation of these
data by the method of Scatchard is presented in Fig. 5.
The binding of GTP[35S] was to a single high-affinity site
with a KD of 15 nm. The Bmxvalue measured in five
separate determinations was 17 + 2 nmol/mg of protein.
Verification that the guanine-nucleotide-binding site
was contained within the 25000 Da protein was
accomplished by photoaffinity labelling with 8-azido-
[y-32P]GTP (Fig. 6). This protein was labelled with
radioligand, and labelling was blocked in a concentra-
tion-dependent manner by GTP[S], but not by 100 ~Itm-
p[NH]ppA. A small amount of non-specific labelling
of the 35000-36000 Da doublet was observed.









Fig. 6. Photoaffinity labelling of the purified protein with
8-azidoly_32PIGTP
Photoaffinity labelling of the purified protein was
accomplished as described in the Experimental section.
The labelled proteins were electrophoresed on an 1-14%
SDS/polyacrylamide gel and stained with Coomassie Blue
(lane a). The gel was dried and used to develop an
autoradiogram (lanes b-f). Lanes (b)-(_f) were loaded with
10 ,sg of protein previously incubated with 8-azido-
[y-32PJGTP under the following conditions: (b) no u.v.
irradiation; (c) u.v. irradiation; (d) u.v. irradiation and
3 /um-GTP[SJ; (e) u.v. irradiation and 30 #m-GTP[S];()
u.v. irradiation and 100 1sm-p(NHJppA.
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Fig. 7. Comparative immunoblot analysis of the 25000 Da GTPISI-binding protein from bovine brain, Gp from human placenta and
G,/G1 from bovine brain
Portions (10 pg/lane for Coomassie Blue staining, panel a; 5 /sg/lane for immunoblots, panels b-d) of the indicated samples
were alkylated, electrophoresed, transblotted, and staining was developed as described in the Experimental section. Placental
Gp (lane 1, panels a, b and c) was purified as previously described. Bovine brain G./Gi (lane 2, panels a, b and c) was
purified through Ultrogel AcA-34 and heptylamine-Sepharose from DEAE-Sephacel fractions 60-84 (see Fig. 1). The 25000 Da
GTP[S]-binding protein from bovine brain (lane 3, panels a, b and c, and panel d) was obtained from the Sephadex G-150 pool
(see Fig. 4; fractions 87-94). The transblotted proteins (panels b-d) were incubated with antisera raised against the a-subunit
of bovine brain Go (panel b), the a-subunit of human platelet Gp (panel c) or oligomeric Gt (panel d).
p[NH]ppA. A small amount of specific binding of
8-azido[y-32P]GTP to a protein smaller than the 25000
Da protein was also observed. This labelling was not
prominent in two other experiments.
The electrophoretic similarity of the 25 000 Da protein
to the GTP-binding protein G previously purified from
human placenta and platelets ty Evans et al. (1986) was
assessed. G purified from human placenta and the
protein purified from bovine brain were electrophoresed
on a series of single-concentration (10%, 12%, 14% and
16%) SDS/polyacrylamide gels. The proteins from both
brain and placenta co-migrated on these gels, as well as
on I1-144% -acrylamide gradient gels. Plots of log Mr
versus RF for each single concentration gel consistently
yielded values for the apparent molecular mass of the
a-subunit of Gp (and the protein from brain) of
24000-25000 Da. Ferguson plots were constructed from
these data, and retardation coefficients (KR) were
obtained (G. L. Waldo, unpublished work). From a
plot of log KR versus log Mr, a molecular mass of
25000 Da was obtained for the two proteins.
The immunological similarities of the two proteins
were also examined by immunoblot analysis (Fig. 7). The
25000 Da proteins from bovine brain and human
placenta were both recognized by polyclonal antiserum
raised against the Gp protein purified from human
platelets (lanes I and 3, Fig. 7c). This antiserum did not
recognize the a-subunits of either Gi or G. (lane 2,
Fig. 7 c). Conversely, antiserum raised against bovine
brain Go (Fig. 7b) recognized the a-subunit of Go, but
not the a-subunit of G, (lane 2) or the 25 000 Da protein
from brain or placenta (lanes 1 and 3). Antiserum raised
against oligomeric Gt recognized the 36000 Da protein,
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Fig. 8. S. aureus V8 protease digestion of bovine brain, human
placental and human platelet 25000 Da GTP-binding
proteins
Approx. 2 ,ug of the brain (lane 2), placental (lane 3) and
platelet (lane 4) proteins were purified by preparative gel
electrophoresis on a 0.75 mm-thick slab of 11%
acrylamide. The 25000 Da proteins were re-electro-
phoresed through a 1.5 mm-thick slab of 15% acrylamide
in the presence of I ,ug of S. aureus V8 protease as
described in the Experimental section. Proteins were
detected by silver staining. Lane I represents 1 jug of the
protease alone.
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which co-purified with the brain protein (25000 Da;
Fig. 7d) and which co-purified with brain GO/G1
and placental Gp (G. L. Waldo, unpublished work).
Coomassie Blue staining of the purified G-proteins is
presented in Fig. 7(a).
Finally, the structural similarity of the proteins
purified from bovine brain, human placenta and human
platelets was assessed by S. aureus V8 protease digestion
of the electrophoretically purified proteins (Fig. 8).
Approx. 2 ,ug of each protein was electrophoresed
through a 15% -polyacrylamide gel in the presence of
1 ,Cg of the protease. The three preparations yielded
identical peptides on proteolysis.
DISCUSSION
It is now widely acknowledged that membrane
preparations from the bovine and rat central nervous
system contain the G-proteins, G,, Gi and G. (Sternweis
& Robishaw, 1984; Neer et al., 1984; Milligan & Klee,
1985; Katada et al., 1986). In this paper we have
demonstrated that membranes from bovine brain also
contain another GTP-binding protein that binds
GTP[35S] with high affinity and is not a substrate for
either pertussis toxin or cholera toxin.
The GTP[35S]-binding activity purified from bovine
brain always was associated with a 25000 Da protein
and a 35000-36000 Da protein doublet. The 25000 Da
protein was photoaffinity labelled by 8-azido[y-32P]GTP
and cross-reacted with antiserum to the putative
a-subunit of a GTP-binding protein called G, recently
purified from human placenta. The 36000 ia protein
was recognized by antibody raised against oligomeric Gt.
The 25000 Da protein from bovine brain always
co-migrated on SDS/PAGE with a similar subunit of
placental Gp, and the 35000-36000 Da doublet always
co-migrated with the fl-subunits from Go, Gi, Gp and Gt
from several sources. The a-subunit of the protein
purified from human placenta was initially assigned a
molecular mass of21000 Da, based on its electrophoretic
co-migration with H-ras (Evans et al., 1986). A more
rigarous estimation of the apparent molecular mass of
the protein was carried out in the present study, and
resulted in a value of approx. 25000 Da. Finally, S.
aureus V8 protease digestion of the 25000 Da proteins
purified from bovine brain, human platelet and placenta
yieded identical peptide maps on SDS/PAGE. On the
basis of these data, the brain protein apparently is
equivalent to the protein called Gp, previously purified
from placenta by Evans et al. (1986). The purified
brain protein was found to consist of approximately
eqwivalent amounts, based on silver or Coomassie Blue
staining, of the 25000 and 35000-36000 Da proteins.
The presence of a potential y-subunit co-purifying with
the GTP[35S]-binding activity was not established in that
SOS/PAGE was not routinely carried out under
conditions where relatively small peptides could be
identified. Nonetheless, a protein(s) of 10000 Da or less
was often observed during SDS/PAGE of the purified
brain protein. Taken together, the co-purification of
the 25000 and 35000/36000 Da proteins, with the
precedence established with other members of the
G-protein family, suggest that a heterotrimeric protein
has been purified. This idea is also consistent with
the fact that the purified protein bound 1 mol of
GTP[35S]/mol of 58000 Da protein. Unequivocal proof
that this protein, like other GTP-binding proteins, is a
functional heterotrimer must await further studies,
including examination of the hydrodynamic properties of
the protein under activating conditions.
Sternweis & Robishaw (1984) have reported that G.
is eluted from DEAE-Sephacel as a trailing shoulder of
the major peak of GTP[35S]-binding activity. Thus, at
least at the initial step of purification, G. has elution
properties similar to those of GX-25000. However, the
GTP-binding protein purified from bovine brain appar-
ently is not contaminated with G.. No cholera-toxin
substrate was found associated with this protein over the
last several column steps. However, this may not be
completely compelling evidence for absence of G., since
optimal conditions for successful cholera-toxin-catalysed
[32P]ADP-ribosylation were not established (see below).
Nevertheless, no 45000 Da protein was found in the
purified fractions from bovine brain. It should be
pointed out that the protein of approx. 47000 Da that
co-purified with the GTP[355}-binding activity through
much of the purification scheme did not co-migrate with
the a-subunit of purified G, under several conditions of
SDS/PAGE.
Kahn & Gilman (1984, 1986) have reported that the
protein cofactor, ARF, necessary for cholera-toxin-
catalysed ADP-ribosylation of the a-subunit of Gs is
itself a GTP-binding protein. This activity is associated
with a doublet of proteins with reported molecular
masses of approx. 21000 Da (Kahn & Gilman, 1984).
Antiserum raised against the protein purified from
placenta does not recognize bovine brain ARF and
anti-ARF antiserum does not recognize the placental
protein (T. Evans, unpublished work). Such observations,
coupled with the failure of brain and liver ARF to bind
guanine nucleotides in the presence of detergent and the
requirement for high ionic strength for such binding
activity (Kahn & Gilman, 1986), make it highly unlikely
that G.-25000 and ARF activity represent the same gene
product.
Owing to the large amounts of Go and GI, it was
difficult to arrive at reliable quantification of the amount
of individual G-proteins in the starting bovine brain
membrane fraction; however, conservative estimates
indicate that 2.5-5% of the GTP[35S]-binding activity
in the cholate extract of bovine brain is associated with
the protein purified here. This would correspond to
approx. 5-10 pmol of this G-protein/mg of membrane
protein, and is clearly a relevant concentration of
protein when compared with the specific activity of
receptors and ion channels in the brain. Demonstra-
tion of functional interaction of this protein with
receptors and/or ion channels is a crucial next step in
confirmation of its potential physiological importance
in brain.
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